Literature DB >> 12296661

Transient postictal magnetic resonance imaging abnormality of the corpus callosum in a patient with epilepsy. Case report and review of the literature.

Aaron A Cohen-Gadol1, Jeftrey W Britton, Clifford R Jack, Jonathan A Friedman, W Richard Marsh.   

Abstract

Transient neuroimaging abnormalities associated with seizure activity have received little attention in the literature. The authors report a focal magnetic resonance (MR) imaging abnormality of the corpus callosum in a patient following a secondary generalized seizure. A 27-year-old right-handed man presented with a history of medically refractory partial seizures since the age of 1 year. The results of an MR imaging study obtained 4 months prior to the patient undergoing video-electroencephalography monitoring were unremarkable. After the patient discontinued all antiepileptic medications, a secondary generalized seizure of right temporal origin was recorded. Five days later, repeated MR imaging revealed a nonenhancing 14 x 11-mm ovoid hyperintense lesion in the splenium of corpus callosum. The patient was asymptomatic, and his neurological and neurocognitive examinations remained unremarkable. Follow-up MR imaging 5 weeks and 1 year later demonstrated near-complete resolution of the lesion. Benign and transient abnormalities in the splenium can occur as a periictal phenomenon. A high index of suspicion and follow-up imaging may prevent further unwarranted intervention.

Entities:  

Mesh:

Year:  2002        PMID: 12296661     DOI: 10.3171/jns.2002.97.3.0714

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  Diffusion-weighted imaging of acute excitotoxic brain injury.

Authors:  Toshio Moritani; Wendy R K Smoker; Yutaka Sato; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

2.  Transient splenium lesions in presurgical epilepsy patients: incidence and pathogenesis.

Authors:  M Nelles; C G Bien; M Kurthen; M von Falkenhausen; H Urbach
Journal:  Neuroradiology       Date:  2006-05-04       Impact factor: 2.804

3.  [Transient splenial lesion in influenza A H1N1 2009 infection].

Authors:  K Linden; O Moser; A Simon; A-M Eis-Hübinger; G Fleischhack; M Born; H Tschampa; T Rosenbaum; B Köster; M Lentze
Journal:  Radiologe       Date:  2011-03       Impact factor: 0.635

Review 4.  Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature.

Authors:  M Conti; A Salis; C Urigo; L Canalis; S Frau; G C Canalis
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

Review 5.  Reversible focal splenial lesions.

Authors:  Massimo Gallucci; Nicola Limbucci; Amalia Paonessa; Ferdinando Caranci
Journal:  Neuroradiology       Date:  2007-05-24       Impact factor: 2.804

6.  Transient splenial lesion: Further experience with two cases.

Authors:  Paramjeet Singh; Dhrubajyoti Gogoi; Sameer Vyas; Niranjan Khandelwal
Journal:  Indian J Radiol Imaging       Date:  2010-11

7.  The enigma of transient splenial hyperintensity: In cryptococcal meningitis.

Authors:  Kaushik Sen; Gautam Guha; Kapil Khandelwal; Joseph Lalhmachhuana
Journal:  J Neurosci Rural Pract       Date:  2013-07

8.  Transient and reversible focal lesion involving the splenium of the corpus callosum in a person with epilepsy.

Authors:  Nitin C Parikh; Makarand Kulkarni
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

9.  Unusual combination of reversible splenial lesion and meningitis-retention syndrome in aseptic meningomyelitis.

Authors:  Nida Tascilar; Hande Aydemir; Ufuk Emre; Aysun Unal; H Tugrul Atasoy; Sureyya Ekem
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Boomerang sign: Clinical significance of transient lesion in splenium of corpus callosum.

Authors:  Hardeep Singh Malhotra; Ravindra Kumar Garg; Mukund R Vidhate; Pawan Kumar Sharma
Journal:  Ann Indian Acad Neurol       Date:  2012-04       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.